Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Psychopathic Violent Offenders? Brains Can?t Understand Punishment

  • Brain region vulnerable to aging is larger in those with longevity gene variant

  • Things smell good for a reason

  • That's using your head: Brain regulates fat metabolism, potentially stopping disease

  • How creative are you? Depends where you're from

  • Drug candidates can block pathway associated with cell death in Parkinson's disease

  • MRIs link impaired brain activity to inability to regulate emotions in autism

  • Decisions on Future Childbearing in Women Diagnosed with a Meningioma

  • Age concern in largest ever study of heroin user deaths

  • Researchers find potential anti-cancer use for anti-epilepsy drug

  •